Brandon D. Smith - Insider Trading & Ownership

Entity
Individual
Location
C/O Impel Pharmaceuticals Inc., 201 Elliott Avenue West, Suite 260, Seattle, WA
All Insider Reports
All Insider Reports

Ownership of Brandon D. Smith

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
IMPL IPI Legacy Liquidation Co Chief Restructuring Officer Dec 18, 2023

There are no insider transactions reported by Brandon D. Smith